November 17, 2026
We are pleased to invite you to one of our four investor sessions, where you will have the opportunity to meet our CEO, the team and learn more about our groundbreaking antibody technology, recent progress, and exciting collaborations.
Above all, you will have the opportunity to ask questions, engage directly with our team, and gain a deeper understanding of our company and the investment opportunity.
We have designed these sessions to be small and personal, creating an environment for conversations, open discussions, and valuable dialogues.
Choose the date that works best for you:
- December 10, 8:30–10:00 AM| Breakfast
- December 16, 1:00–2:30 PM| Afternoon Coffee
- January 13, 9:00–10:30 AM| Breakfast
- January 15, 3:30–5:00 PM| Afternoon Coffee
Register here:
https://tally.so/r/5Xjx4Z
Location: Mesenkia Therapeutics, Majoren, Dag Hammarskjölds väg 26, Uppsala, Sweden
Contact: Jenny Lundell, Business Development & IR: jenny.lundell@mesenkia.com
We are looking forward meeting you, Welcome!